Facebook, Inc. (FB) Message Board
-
Lung function test and REMS are huge negatives for Afrezza.
p.s. Afrezza doesn't eliminate needles. -
Minimum: .15
Maximum: .35
Place your bet. -
Buy "AMBS" at under a nickle.
Triple by September 1.
IMHO. -
What do you think will happen to the share price when Israel attempts to take out Iran's nuclear facilities?
What's the probability that it happens within the next 90 days? -
The company is sponsoring the NFL Head Injury symposium to be held later this month in Minneapolis.
Due diligence. -
.25 by September 1.
Don't bet against Napadano's valuation. -
The next ACAD.
Get in today under a dime.
Patented MANF technology could be worth billions.
Partnership news is imminent according to the company's C.E.O. -
On sale at .64.
-
GSS
-
Partnership news is imminent.
Substantial upside from here.
Get in today under a dime.
The company's patented MANF technology could be worth billions. -
Diagnostic partnership to be announced. Brain injury symposium in Minneapolis. G.E./N.F.L. grant may be announced. MJFF grant in the works.
Time to add a few shares.
GLTA. -
Not if but when.
-
Most undervalued gold company.
-
More upside than ARNA.
-
Over $2,000,000,000 in known gold reserves. Currently trading on the AMEX at less than $1.00 share.
Potential buyout target. - Reply to
Great candidate for a buyout bigger players can extract the 2 mill ounces in reseves cheaper then they can
by trader5632 •Jun 6, 2013 12:39 PMNot if but when. There will be substantial consolidation in the gold industry.
This is substantially undervalued. -
Declining daily trading volume. Positive news could double this overnight.
-
Takeover at double the current price is realistic.
-
Industry consolidation could make it a takeover target at twice the current price.
-
Takeover target at twice the current price.